Literature DB >> 8540518

Fulminant hepatic failure as the initial manifestation of non-Hodgkins lymphoma.

P Ghosh1, I J Fox, A M Rader, M F Sorrell.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8540518

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  7 in total

1.  Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy.

Authors:  Yasser M Bhat; Alyssa Krasinskas; Fiona E Craig; Thomas A Shaw-Stiffel
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases.

Authors:  D Rowbotham; J Wendon; R Williams
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

3.  Malignant infiltration of the liver presenting as acute liver failure.

Authors:  Nicole E Rich; Corron Sanders; Randall S Hughes; Robert J Fontana; R Todd Stravitz; Oren Fix; Steven H Han; Willscott E Naugler; Atif Zaman; William M Lee
Journal:  Clin Gastroenterol Hepatol       Date:  2014-09-30       Impact factor: 11.382

4.  Acute liver failure as a rare initial manifestation of peripheral T-cell lymphoma.

Authors:  Michael L Davis; Nikroo Hashemi
Journal:  World J Hepatol       Date:  2010-10-27

5.  Massive infiltration of liver by metastatic adenocarcinoma: a rare cause of acute hepatic failure.

Authors:  Joy Varghese; Venkataraman Jayanthi; Susma Patra; Mohamed Rela
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 6.  Angiosarcoma of the liver as a cause of fulminant liver failure.

Authors:  Marco Montell García; Raúl Romero Cabello; Raul Romero Feregrino; Mercado Atri Moises; Rafael Trejo Estrada; Padilla-Rodríguez Alvaro; Gama Moreno Manlio Gerardo; Romero Feregrino Rodrigo
Journal:  BMJ Case Rep       Date:  2012-08-02

Review 7.  Acute liver failure due to primary angiosarcoma: a case report and review of literature.

Authors:  Chandra S Bhati; Anand N Bhatt; Graham Starkey; Stefan G Hubscher; Simon R Bramhall
Journal:  World J Surg Oncol       Date:  2008-09-30       Impact factor: 2.754
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.